Ronald Muhlenkamp
Muhlenkamp & Co
Ronald Muhlenkamp Globus Medical stake
total: 197
Muhlenkamp & Co GMED trades
- Total transactions:
- 5
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 2
- Held since:
- 2013 Q2 or earlier
- Held for:
- 4+ quarters
- Latest activity:
- 2014 Q2
According to 2026 Q2 report, Ronald Muhlenkamp doesn't hold any Globus Medical (GMED) shares. Muhlenkamp & Co has held GMED since at least 2013 Q2 with 96,150 shares in our earliest available record. Since at least 2013 Q2, Muhlenkamp & Co has made 4 more transactions.
When did Ronald Muhlenkamp sell Globus Medical (GMED)?
Ronald Muhlenkamp sold off the entire Globus Medical (GMED) position in 2014 Q2.
Estimated cost basis*
- Weighted AVG buy price:
- $17.41
- Weighted AVG sell price:
- $26.41
Ronald Muhlenkamp's historical trades in Globus Medical
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2014 Q2
|
0.00%
|
$26.59
|
-100% (-51,480)
|
|||
|
2014 Q1
|
0.24%
|
$26.59
|
-54.39% (-61,395)
|
|||
|
2013 Q4
|
0.40%
|
$20.18
|
+20.33% (+19,070)
|
|||
|
2013 Q3
|
0.33%
|
$17.46
|
-2.44% (-2,345)
|
|||
|
2013 Q2
|
0.34%
|
$16.86
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.